THE conception that drugs act by metabolic interference has been latent in pharmacology throughout the growth of chemotherapy and biochemistry. This note traces its development to the status of a ...

Cancer chemotherapy needs to be tailored to the individual, and needs to take into consideration the phases of aging and associated comorbidities. Physiological changes and clinical pharmacology ...

Triple-negative breast cancer, an aggressive type of breast cancer, accounts for 10% of all breast cancer cases in the United ...

THIO has gained its generic name and preclinical data on a different form of the cancer drug suggests it could improve chemotherapy efficacy.

said lead researcher John Streicher, Ph.D., a member of the Comprehensive Center for Pain & Addiction and a professor of pharmacology ... they used a mouse model of chemotherapy-induced ...